Go to
JCI Insight
Citations to this article
Christopher T. Hensley, … , Ajla T. Wasti, Ralph J. DeBerardinis
Published September 3, 2013
Citation Information: J Clin Invest. 2013;123(9):3678-3684. https://doi.org/10.1172/JCI69600.
Citation Information: J Clin Invest. 2013;123(9):3678-3684. https://doi.org/10.1172/JCI69600.
Abstract
Glutamine is an abundant and versatile nutrient that participates in energy formation, redox homeostasis, macromolecular synthesis, and signaling in cancer cells. These characteristics make glutamine metabolism an appealing target for new clinical strategies to detect, monitor, and treat cancer. Here we review the metabolic functions of glutamine as a super nutrient and the surprising roles of glutamine in supporting the biological hallmarks of malignancy. We also review recent efforts in imaging and therapeutics to exploit tumor cell glutamine dependence, discuss some of the challenges in this arena, and suggest a disease-focused paradigm to deploy these emerging approaches.
Authors
Christopher T. Hensley, Ajla T. Wasti, Ralph J. DeBerardinis
Total citations by year
Citation information
Citations to this article (672)
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)